Project Grant HT94252410818
Award Date
8/12/24
Completion Date
8/11/27
Dollars Obligated
$644K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Dayton, OH 45435, USA
Similar Awards
Wayne State University was awarded a $538,792 project grant from the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420) to conduct research titled "Targeting TINAGL1 to Enhance Immunotherapy Response in Lung Cancer." The three-year award beginning May 1, 2023 will support the university's efforts to investigate medical solutions for battlefield injuries and transform military and public health care through innovative biomedical research....
The Defense Health Agency awarded Wayne State University a $616,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to investigate the molecular mechanisms and therapeutic potential of the RNA methyltransferase FTSJ3 in regulating ribosome biogenesis in liver cancer. The project will be conducted over a 2-year period from September 30, 2023 to September 29, 2025. As a premier public research university, Wayne State University has a track record of...
The Washington University Office of Sponsored Research Services Division received a $226,471.00 Project Grant from the Defense Health Agency under the Department of Defense's CFDA 12.420 Military Medical Research and Development program. The grant, awarded on Sep 30, 2023, will fund a study on the "PHOSPHORYLATION TAU PROFILE OF VETERANS WITH TBI" through Sep 29, 2026. As a leading research institution with expertise in biomedical research, the university will leverage its capabilities...
The Department of Defense's Defense Health Agency awarded a $155,500 Project Grant to The Washington University's Office of Sponsored Research Services Division to support a research project titled "ACTIVATION OF AN IMMUNE EVASION-TO-IMMUNE RECOGNITION SWITCH THROUGH THE INDUCTION OF IRF3 SIGNALING IN CRPCS". The grant, funded through the Military Medical Research and Development program (CFDA 12.420), will be executed over a 2-year period from May 1, 2024 to April 30, 2026. The...
The U.S. Department of Defense's Defense Health Agency awarded a $693,000 Project Grant to Wayne State University in Detroit, Michigan under the Military Medical Research and Development program (CFDA 12.420). The grant supports the university's "EPIGENETIC THERAPEUTIC TARGETING OF ENHANCER HUBS FOR BREAST CANCER" research project, which aims to develop new treatments for breast cancer. The 3-year award, running from December 15, 2023 to December 14, 2026, will fund basic,...
The Defense Health Agency awarded a $512,751.00 Project Grant to The Ohio State University for the period from July 1, 2023 to June 30, 2026. The grant was provided under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the American public through innovative and impactful research, and to investigate medical solutions for the battlefield. The grant funds will...
The Department of Defense's Defense Health Agency awarded a $1,127,375 Project Grant to The Washington University Office of Sponsored Research Services Division under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from Sep 30, 2023 to Sep 29, 2027, will fund research on "REPLICATION DRIVEN VULNERABILITIES IN CYCLIN E OVEREXPRESSING OVARIAN CANCERS". As a prominent research institution with expertise in biomedical sciences, The Washington...
This $924,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at Wayne State University to target dual-specificity phosphatase 1 in platinum resistance in ovarian cancer. The award, which runs from July 1, 2024 to June 30, 2028, will enable Wayne State to conduct innovative scientific studies to improve treatment options and outcomes for this challenging form of cancer, which disproportionately impacts...
The University of Toledo received a $1.7 million project grant award from the Defense Health Agency on September 15, 2021 to complete work by August 14, 2025. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care. Specifically, the University will investigate maladaptive nigrovagal pathophysiology in parkinsonism under this award. The research aims to...
This $385,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports Wayne State University's research to develop therapeutic approaches targeting spiral ganglion-cochlear nucleus synaptopathy. The two-year award, running from September 1, 2023 to August 31, 2025, aims to transform health care for Service Members and the American public through innovative and impactful biomedical research. As a prominent public...